Prolongation of survival of an allograft by inhibiting complement activity

Details for Australian Patent Application No. 2007224250 (hide)

Owner Alexion Pharmaceuticals, Inc.

Inventors Rother, Russell P.; Zhong, Zhen; Wang, Hao

Agent Shelston IP

Pub. Number AU-B-2007224250

PCT Pub. Number WO2007/103134

Priority 60/778,859 02.03.06 US

Filing date 2 March 2007

Wipo publication date 13 September 2007

Acceptance publication date 3 May 2012

International Classifications

A61K 31/00 (2006.01)

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/365 (2006.01) - Lactones

A61K 31/573 (2006.01)

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/13 (2006.01) Medicinal preparations containing peptides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

Event Publications

18 September 2008 PCT application entered the National Phase

  PCT publication WO2007/103134 Priority application(s): WO2007/103134

3 May 2012 Application Accepted

  Published as AU-B-2007224250

30 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007224254-Yielding post guardrail safety system incorporating thrie beam guardrail elements

2007224240-Methods for distinguishing isomers using mass spectrometry